Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 371-380 of 456 for breast cancer

Edit search filters
  1. A Study of the Ability to Predict Lymphedema Development Following Axillary Surgery for Breast Cancer and Its Effects on Patient Survivorship

    Jacksonville, FL

  2. Evaluating Surgical Treatment Related Differences in Patient Satisfaction and Health-related Quality of Life in Breast Cancer Survivors in the Long-term Survivorship Period

    Rochester, MN

  3. A Study to Evaluate Left and Right Ventricular Function in Relation to Exercise Capacity in Breast Cancer Survivors

    Jacksonville, FL

  4. Comparing the Investigational Imaging System with Sonography

    Rochester, MN

  5. ADVANCE 2: ADdressing Views of African AmericaNs on CancEr Screening

    Jacksonville, FL, Rochester, MN, Scottsdale/Phoenix, AZ

  6. A Study to Understand the Connections of Genetic Variation and Mammographic Density within the Mountain Park Health Center Mammography Study

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Plasma Proneurotensin as a Predictive Biomarker for Breast Cancer in Genetically Predisposed Patients

    Rochester, MN

  9. A Single Patient Study of Severe Fibrosis after Breast Radiation

    Rochester, MN

  10. Immune Control of Breast Cancer Tumor Dormancy

    Rochester, MN

.

Mayo Clinic Footer